We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

94 hedge funds and large institutions have $119M invested in AVEO Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 30 increasing their positions, 13 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

552% more call options, than puts

Call options by funds: $13.7M | Put options by funds: $2.1M

131% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 13

24% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 25

4% more funds holding

Funds holding: 90 → 94 (+4)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

31% less capital invested

Capital invested by funds: $173M → $119M (-$54.5M)

Holders
94
Holders Change
+4
Holders Change %
+4.44%
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
31
Increased
30
Reduced
13
Closed
25
Calls
$13.7M
Puts
$2.1M
Net Calls
+$11.6M
Net Calls Change
+$2.55M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$12.1M
2
NMC
NEA Management Company
Maryland
+$3.37M
3
State Street
State Street
Massachusetts
+$3.36M
4
Northern Trust
Northern Trust
Illinois
+$2.08M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$1.12M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$9.37M
2
Millennium Management
Millennium Management
New York
-$3.9M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$2.73M
4
PM
Prosight Management
Texas
-$2.12M
5
Goldman Sachs
Goldman Sachs
New York
-$1.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
GIM
26
Granahan Investment Management
Massachusetts
$406K +$59.6K +2,513 +16%
AQR Capital Management
27
AQR Capital Management
Connecticut
$358K +$375K +15,829 New
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$352K +$369K +15,555 New
PM
29
Prosight Management
Texas
$337K -$2.12M -89,448 -86%
TA
30
Teachers Advisors
New York
$292K +$307K +12,933 New
Wells Fargo
31
Wells Fargo
California
$281K +$25.1K +1,058 +9%
BC
32
Birchview Capital
Vermont
$226K – – –
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$209K +$220K +9,264 New
Manulife (Manufacturers Life Insurance)
34
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$191K +$191K +8,066 +2,222%
New York State Common Retirement Fund
35
New York State Common Retirement Fund
New York
$155K +$163K +6,880 New
AIG
36
American International Group
New York
$150K +$157K +6,621 New
Creative Planning
37
Creative Planning
Kansas
$143K +$150K +6,310 New
UBS Group
38
UBS Group
Switzerland
$129K +$136K +5,724 +57,240%
California Public Employees Retirement System
39
California Public Employees Retirement System
California
$124K +$51.1K +2,156 +65%
QIM
40
Quantitative Investment Management
Virginia
$121K +$128K +5,380 New
RCAG
41
Rehmann Capital Advisory Group
Michigan
$120K – – –
SSA
42
Schonfeld Strategic Advisors
New York
$113K -$60.1K -2,533 -34%
Wolverine Trading
43
Wolverine Trading
Illinois
$109K – – –
Citadel Advisors
44
Citadel Advisors
Florida
$101K +$106K +4,490 New
FNBT
45
FineMark National Bank & Trust
Florida
$90K +$47.4K +2,000 +100%
CHAM
46
Clear Harbor Asset Management
Connecticut
$86K +$23.7K +1,000 +36%
VOYA Investment Management
47
VOYA Investment Management
Georgia
$85K +$89.7K +3,782 New
Invesco
48
Invesco
Georgia
$76K +$79.8K +3,365 New
Principal Financial Group
49
Principal Financial Group
Iowa
$72K +$26.5K +1,119 +54%
CC
50
Cannell & Co
New York
$68K +$47.4K +2,000 +200%
1
2
3 4 5

AVEO Hedge Fund Activity: Q2 2018 in Review

94 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q2 2018, worth a combined $119M — down 31% from $173M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new AVEO positions and 25 closed out — a net gain of 6 holders — while 30 added to existing stakes and 13 trimmed.

The largest buyer was BlackRock, adding an estimated $12.1M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $9.37M sold.

  • 94 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q2 2018, up from 90 in Q1 2018.
  • Funds reported $119M of AVEO Pharmaceuticals, Inc. stock for Q2 2018, down 31% quarter-over-quarter.
  • 31 funds opened new AVEO Pharmaceuticals, Inc. positions in Q2 2018 and 25 closed out, a net change of +6 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q2 2018 was BlackRock, an estimated $12.1M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q2 2018 was Avoro Capital Advisors, an estimated $9.37M sold.

Based on aggregated 13F filings for Q2 2018.